JPWO2023201423A5 - - Google Patents
Info
- Publication number
- JPWO2023201423A5 JPWO2023201423A5 JP2024562090A JP2024562090A JPWO2023201423A5 JP WO2023201423 A5 JPWO2023201423 A5 JP WO2023201423A5 JP 2024562090 A JP2024562090 A JP 2024562090A JP 2024562090 A JP2024562090 A JP 2024562090A JP WO2023201423 A5 JPWO2023201423 A5 JP WO2023201423A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- independently selected
- pharmaceutically acceptable
- prodrug
- solvate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263332450P | 2022-04-19 | 2022-04-19 | |
| US63/332,450 | 2022-04-19 | ||
| PCT/CA2023/050523 WO2023201423A1 (en) | 2022-04-19 | 2023-04-18 | Indoline derivatives as serotonergic agents useful for the treatment of disorders related thereto |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025513462A JP2025513462A (ja) | 2025-04-24 |
| JP2025513462A5 JP2025513462A5 (https=) | 2026-04-23 |
| JPWO2023201423A5 true JPWO2023201423A5 (https=) | 2026-04-23 |
Family
ID=88418733
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024562090A Pending JP2025513462A (ja) | 2022-04-19 | 2023-04-18 | セロトニン作動薬としてのインドリン誘導体に関連する障害の治療に有用なセロトニン作動薬としてのインドリン誘導体 |
| JP2024562088A Pending JP2025513461A (ja) | 2022-04-19 | 2023-04-18 | セロトニン作動薬としてのインドリン誘導体に関連する障害の治療に有用なセロトニン作動薬としてのインドリン誘導体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024562088A Pending JP2025513461A (ja) | 2022-04-19 | 2023-04-18 | セロトニン作動薬としてのインドリン誘導体に関連する障害の治療に有用なセロトニン作動薬としてのインドリン誘導体 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20250353827A1 (https=) |
| EP (2) | EP4511369A4 (https=) |
| JP (2) | JP2025513462A (https=) |
| KR (2) | KR20250034020A (https=) |
| CN (2) | CN119546591A (https=) |
| AU (2) | AU2023258059A1 (https=) |
| CA (2) | CA3248179A1 (https=) |
| IL (2) | IL316401A (https=) |
| MX (2) | MX2024012865A (https=) |
| WO (2) | WO2023201421A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL318929A (en) * | 2022-08-29 | 2025-04-01 | Mindset Pharma Inc | Indoline derivatives as serotonergic agents useful for the treatment of related disorders |
| WO2025104491A1 (en) * | 2023-11-14 | 2025-05-22 | Mindset Pharma Inc. | Indole derivatives as serotonergic agents useful for the treatment of disorders related thereto |
| WO2025123137A1 (en) * | 2023-12-15 | 2025-06-19 | 10763942 Canada Inc. (Dba. Purminds Neuropharma) | Heterocyclic compounds and methods of preparation thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2737725B1 (fr) * | 1995-08-08 | 1997-10-31 | Valentonine | Nouveaux derives acyles de la melatonine et d'analogues melatoninergiques, leur procede de preparation et leur utilisation en tant que medicament |
| EP0944595B1 (en) * | 1996-11-26 | 2003-10-01 | NPS Allelix Corp. | 5-cyclo indole compounds as 5-ht1d receptor ligands |
| CZ295937B6 (cs) * | 1997-07-25 | 2005-12-14 | H. Lundbeck A/S | Indolové nebo 2,3-dihydroindolové deriváty |
| GB9819033D0 (en) * | 1998-09-01 | 1998-10-28 | Cerebrus Ltd | Chemical compounds VI |
| US6608079B1 (en) * | 1998-12-11 | 2003-08-19 | Eli Lilly And Company | Indole derivatives and their use as 5-HT1F agonists |
| AU2003236207A1 (en) * | 2002-05-31 | 2003-12-19 | H. Lundbeck A/S | The hydrochloride of (s)-(+)-3-(1-(2-(1-acetyl-2,3-dihydro-1h-indol-3-yl)ethyl)-1,2,3,6-tetrahydropyridin-4-yl)-6-chloro-1h-indole |
| WO2005084664A1 (ja) * | 2004-03-08 | 2005-09-15 | Kanazawa University Technology Licensing Organization Ltd. | インドール誘導体及びその用途 |
| CL2007002166A1 (es) * | 2006-07-24 | 2008-01-25 | Tetralogic Pharm Corp | Compuestos derivados de heterociclos de nitrogeno, antagonistas de los inhibidores de las proteinas de la apoptosis; sus composiciones farmaceuticas; y uso de dichos compuestos para el tratamiento del cancer. |
| MX2022009528A (es) * | 2020-02-04 | 2022-11-14 | Mindset Pharma Inc | Derivados de 3-pirrolidina-indol como agentes psicodélicos serotoninérgicos para el tratamiento de trastornos del snc. |
-
2023
- 2023-04-18 KR KR1020247038407A patent/KR20250034020A/ko active Pending
- 2023-04-18 WO PCT/CA2023/050521 patent/WO2023201421A1/en not_active Ceased
- 2023-04-18 EP EP23790806.6A patent/EP4511369A4/en active Pending
- 2023-04-18 US US18/857,230 patent/US20250353827A1/en active Pending
- 2023-04-18 JP JP2024562090A patent/JP2025513462A/ja active Pending
- 2023-04-18 JP JP2024562088A patent/JP2025513461A/ja active Pending
- 2023-04-18 CA CA3248179A patent/CA3248179A1/en active Pending
- 2023-04-18 AU AU2023258059A patent/AU2023258059A1/en active Pending
- 2023-04-18 IL IL316401A patent/IL316401A/en unknown
- 2023-04-18 CA CA3248170A patent/CA3248170A1/en active Pending
- 2023-04-18 EP EP23790804.1A patent/EP4511360A4/en active Pending
- 2023-04-18 KR KR1020247038406A patent/KR20250036719A/ko active Pending
- 2023-04-18 AU AU2023255414A patent/AU2023255414A1/en active Pending
- 2023-04-18 IL IL316416A patent/IL316416A/en unknown
- 2023-04-18 US US18/857,234 patent/US20260083703A1/en active Pending
- 2023-04-18 WO PCT/CA2023/050523 patent/WO2023201423A1/en not_active Ceased
- 2023-04-18 CN CN202380048473.6A patent/CN119546591A/zh active Pending
- 2023-04-18 CN CN202380048482.5A patent/CN119522212A/zh active Pending
-
2024
- 2024-10-17 MX MX2024012865A patent/MX2024012865A/es unknown
- 2024-10-17 MX MX2024012864A patent/MX2024012864A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2021155468A5 (https=) | ||
| JP7607732B2 (ja) | 置換ピロロピリミジンｊａｋ阻害剤ならびにこれを作製および使用する方法 | |
| IL295371A (en) | Psilocyin derivatives as serotonergic psychedelics for the treatment of central nervous system disorders | |
| ES2935476T3 (es) | Esteroides neuroactivos, composiciones y usos de los mismos | |
| JP2019520416A5 (https=) | ||
| JPWO2021155470A5 (https=) | ||
| IL316401A (en) | Indoline derivatives as estrogenic agents for the treatment of disorders | |
| JP2018505898A5 (https=) | ||
| RU2009103307A (ru) | ПРОИЗВОДНЫЕ ИМИДАЗО[1, 2-a]ПИРИДИН-2-КАРБОКСАМИДОВ, ИХ ПОЛУЧЕНИЕ И ПРИМЕНЕНИЕ В ТЕРАПИИ | |
| JP6046149B2 (ja) | Ｈ３受容体阻害剤としてのピペリジン及びピペラジン環を含むカルバメート／尿素誘導体 | |
| AU2017207991A1 (en) | Pyridazine derivatives as EAAT2 activators | |
| JP7794910B2 (ja) | Ｅａａｔ２活性化因子およびその使用方法 | |
| JP2020517607A5 (https=) | ||
| US20190382373A1 (en) | 6-AMINOPYRIDIN-3-YL PYRAZOLES AS MODULATORS OF RORgT | |
| JPWO2010150840A1 (ja) | Ｎ−置換−環状アミノ誘導体 | |
| ES2548683T3 (es) | Amidas del ácido 4-(5-isoxazolil o 5-pirrazolil-1,2,4-oxadiazol-3-il)-mandélico como agonistas de receptor de esfingosina-1-fosfato 1 | |
| JPWO2023201423A5 (https=) | ||
| JP2012149054A (ja) | Ｎ−置換−環状アミノ誘導体からなる医薬 | |
| JPWO2023201421A5 (https=) | ||
| JP2008508251A5 (https=) | ||
| JPWO2021155467A5 (https=) | ||
| AR034158A1 (es) | Derivados de 1-aminobutano-3-ol sustituidos, procedimientos para su preparacion, medicamentos que contienen estos compuestos y el uso de derivados de 1-aminobutano-3-ol sustituidos para la preparacion de medicamentos | |
| JPWO2021050824A5 (https=) | ||
| JPWO2022120475A5 (https=) | ||
| JP2019535715A5 (https=) |